EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Medication Use and Risk of Microscopic Colitis: A Propensity‐Matched Analysis of US Adults ≥ 50 Years (2014–2024)

Yassine Kilani iD, Farah Heis, Andrew Dugaesescu, Youssef Hafez iD, Shadi Hamdeh, Wissam Kiwan, Mahmoud Y Madi iD

Alimentary Pharmacology & Therapeutics · 21.09.2026

DOI: 10.1111/apt.70985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 21.09.2026. Verfasst von Yassine Kilani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between medications—including non‐steroidal anti‐inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs) and selective serotonin reuptake inhibitors (SSRIs)—and microscopic colitis (MC) remains controversial. While earlier studies suggested increased risk, more recent analyses have challenged these findings, citing methodological limitations. We evaluated the risk of MC among commonly implicated medications using a large national U.S. database.

Methods

Using the TriNetX database (2014–2024), we conducted a retrospective cohort study including adults ≥ 50 years with at least one documented healthcare encounter and no prior MC or inflammatory bowel disease. Exposure was defined as ≥ 3 prescriptions within a drug class. Treatment groups (NSAIDs, PPIs, SSRIs, ACE inhibitors [ACEIs], angiotensin receptor blockers [ARBs], statins) were 1:1 propensity score‐matched (PSM) to untreated controls on age, sex, race, comorbidities and previous colonoscopy. The primary outcome was incident MC, identified by new diagnostic codes. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs).

Results

After PSM, cohorts included 907,266 NSAID, 750,009 PPI, 308,310 SSRI, 393,952 ACEI, 298,480 ARB users and 548,339 statin users. Over 2 years, MC risk was increased with NSAIDs (HR 1.15; 95% CI, 1.02–1.30), PPIs (HR 1.36; 95% CI, 1.19–1.54) and SSRIs (HR 1.52; 95% CI, 1.27–1.83). ACEIs, ARBs and statins were not associated with MC.

Conclusions

In this large cohort, NSAIDs, PPIs and SSRIs were associated with an increased risk of MC, whereas no significant association was observed for ACEIs, ARBs or statins. Medication review should be considered in patients with new‐onset chronic diarrhoea.

Schlagwörter

Stichwörter der Autor:innen

collagenous colitislymphocytic colitismedication exposuremicroscopic colitispropensity score matchingreal‐world evidence

Autor:innen und Institutionen

  • Division of General Internal Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA.
  • Saint Louis University School of Medicine, St Louis, Missouri, USA.
  • Division of Gastroenterology & Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri, USA.
  • Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Missouri, USA.
  • Division of Gastroenterology and Hepatology, The University of Texas at Austin Dell Medical School, Austin, Texas, USA.

ORCID-Profile: Yassine Kilani, Youssef Hafez, Mahmoud Y Madi

Zitieren

APA

Kilani, Y., Heis, F., Dugaesescu, A., Hafez, Y., Hamdeh, S., Kiwan, W., & Madi, M. Y. (2026). Medication Use and Risk of Microscopic Colitis: A Propensity‐Matched Analysis of US Adults ≥ 50 Years (2014–2024). Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70985

Vancouver

Kilani Y, Heis F, Dugaesescu A, Hafez Y, Hamdeh S, Kiwan W, et al. Medication Use and Risk of Microscopic Colitis: A Propensity‐Matched Analysis of US Adults ≥ 50 Years (2014–2024). Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.70985

BibTeX
@article{Kilani2026,
  author = {Kilani, Yassine and Heis, Farah and Dugaesescu, Andrew and Hafez, Youssef and Hamdeh, Shadi and Kiwan, Wissam and Madi, Mahmoud Y},
  title = {Medication Use and Risk of Microscopic Colitis: A Propensity‐Matched Analysis of US Adults ≥ 50 Years (2014–2024)},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.70985}
}
Kostenlos starten →